Browsing byAuthor강덕희

Jump to:
All A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
  • Sort by:
  • In order:
  • Results/Page
  • Authors/Record:

Showing results 117 to 146 of 162

Issue DateTitleAuthor(s)Type
2017Screening of breast cancer stem cell inhibitors using a protein kinase inhibitor library강덕희; 오억수; 최학선; 김달아; 정희성Article
2017Selective tubular activation of hypoxia-inducible factor-2 alpha has dual effects on renal fibrosis강덕희; 최규복; 권기환; 김승정; 한기환; 류동열; 최윤희; 김민석Article
2006Serum uric acid: A risk factor and a target for treatment?강덕희Conference Paper
2005Subtle renal injury is likely a common mechanism for salt-sensitive essential hypertension강덕희Short Survey
2014Syndecan-2 regulates melanin synthesis via protein kinase C βII-mediated tyrosinase activation강덕희; 오억수Article
2009Systemic inflammation, metabolic syndrome and progressive renal disease강덕희Review
2019Tannic acid attenuates the formation of cancer stem cells by inhibiting NF-kappa B-mediated phenotype transition of breast cancer cells강덕희; 오억수; 유은선; 최학선; 김달아Article
2013Targeting syndecans: A promising strategy for the treatment of cancer강덕희; 오억수Review
2016Technique failure in Korean incident peritoneal dialysis patients: a national population-based study한후재; 강덕희; 최규복; 김승정; 류동열Article
2004TGF-beta induces proangiogenic and antiangiogenic factors via parallel but distinct Smad pathways강덕희Article
2017The additional benefit of weighted subjective global assessment (SGA) for the predictability of mortality in incident peritoneal dialysis patients: A prospective study강덕희; 최규복; 김승정; 류동열Article
2009The association between fetal and postnatal growth status and serum levels of uric acid in children at 3 years of age하은희; 강덕희; 박은애; 김영주; 박혜숙; 이화영; 조수진; 박보현Article
2019The case for uric acid-lowering treatment in patients with hyperuricaemia and CKD강덕희Article
2013The extracellular domain of syndecan-2 regulates the interaction of HCT116 human colon carcinoma cells with fibronectin강덕희; 오억수; 박성수Article
2004The Impact of Gender on Progression of Renal Disease: Potential Role of Estrogen-Mediated Vascular Endothelial Growth Factor Regulation and Vascular Protection윤견일; 강덕희Article
2003The impact of gender on progression of renal disease: Potential role of estrogen-mediated VEGF regulation and vascular protection.강덕희; 유은선Meeting Abstract
2019The interactive effects of input and output on managing fluid balance in patients with acute kidney injury requiring continuous renal replacement therapy강덕희; 최규복; 김승정; 류동열; 이지은; 이신아; 오형중; 이혜아Article
2016The relationship between magnesium and endothelial function in end-stage renal disease patients on hemodialysis강덕희; 최규복; 김승정; 류동열Article
2013The role of uric acid in the pathogenesis of human cardiovascular disease강덕희Review
2004Transplant graft vasculopathy: An emerging target for prevention and treatment of renal allograft dysfunction강덕희Review
2003Tubulointerstitial disease: Role of ischemia and microvascular disease강덕희Review
2006Unearthing uric acid: An ancient factor with recently found significance in renal and cardiovascular disease강덕희Short Survey
2011Uric Acid and Chronic Kidney Disease: New Understanding of an Old Problem강덕희Article
2013Uric acid and chronic kidney disease: Which is chasing which?강덕희Review
2005Uric acid and chronic renal disease: Possible implication of hyperuricemia on progression of renal disease강덕희Review
2005Uric acid and preeclampsia강덕희Review
2014Uric acid and the kidney강덕희Book Chapter
2005Uric acid as a mediator of endothelial dysfunction, inflammation, and vascular disease강덕희Review
2013Uric acid attenuates nitric oxide production by decreasing the interaction between endothelial nitric oxide synthase and calmodulin in human umbilical vein endothelial cells: A mechanism for uric acid-induced cardiovascular disease development강덕희; 조인호; 박정현Article
2005Uric acid causes vascular smooth muscle cell proliferation by entering cells via a functional urate transporter강덕희Article

BROWSE